Human miR-137 putative targets |
Biological functions |
Cancer | < 0.001 | 531 |
Organismal death | < 0.001 | 238 |
Size of body | < 0.001 | 98 |
Movement disorders | < 0.001 | 117 |
Locomotion | < 0.001 | 45 |
Neuritogenesis | < 0.001 | 58 |
Learning | < 0.001 | 51 |
Epilepsy | < 0.001 | 40 |
Action potential of neurons | < 0.001 | 22 |
Chorea | < 0.001 | 72 |
Canonical pathways |
PAK signalling | 0.002 | 16 |
Protein kinase A signalling | 0.003 | 39 |
Ephrin receptor signalling | 0.006 | 22 |
Paxillin signalling | 0.008 | 15 |
Agrin Interactions at neuromuscular junction | 0.008 | 12 |
Cardiac β-adrenergic signalling | 0.009 | 18 |
D-myo-inositol-5-phosphate metabolism | 0.009 | 18 |
SAPK/JNK signalling | 0.009 | 14 |
Glucocorticoid receptor signalling | 0.009 | 27 |
Sertoli cell-sertoli cell junction signalling | 0.009 | 21 |
Mouse miR-137 putative targets |
Biological functions |
Organismal death | < 0.001 | 200 |
Cancer | < 0.001 | 410 |
Size of body | < 0.001 | 84 |
Development of muscle | < 0.001 | 43 |
Neurotransmission | < 0.001 | 46 |
Development of digestive system | < 0.001 | 39 |
Locomotion | < 0.001 | 37 |
Action potential of neurons | < 0.001 | 19 |
Morphogenesis of embryonic limb | < 0.001 | 15 |
Morphogenesis of forelimb | < 0.001 | 9 |
Canonical pathways |
Paxillin signalling | < 0.001 | 17 |
PAK signalling | < 0.001 | 16 |
Agrin Interactions at neuromuscular junction | < 0.001 | 12 |
Ephrin receptor signalling | 0.003 | 18 |
Axonal guidance signalling | 0.003 | 34 |
Glucocorticoid receptor signalling | 0.004 | 24 |
Ephrin A signalling | 0.004 | 9 |
Rac signalling | 0.006 | 13 |
Protein kinase A signalling | 0.006 | 30 |
Sertoli cell-sertoli cell junction signalling | 0.006 | 18 |